OncoMed Pharmaceuticals Inc Insider Trading for August 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OncoMed Pharmaceuticals Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in OncoMed Pharmaceuticals Inc for August 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 25 2014 | OMED | OncoMed Pharmaceut ... | Gurney Austin | See Remarks | Sell | S | 20.00 | 4,000 | 80,000 | 97,532 | 101.5 K to 97.5 K (-3.94 %) |
| Aug 21 2014 | OMED | OncoMed Pharmaceut ... | PAKIANATHAN DEEPIKA | Director | Buy | P | 18.98 | 201 | 3,815 | 18,940 | 18.7 K to 18.9 K (+1.07 %) |
| Aug 21 2014 | OMED | OncoMed Pharmaceut ... | PAKIANATHAN DEEPIKA | Director | Buy | P | 18.98 | 21,402 | 406,171 | 1,991,602 | 2 M to 2 M (+1.09 %) |
| Aug 21 2014 | OMED | OncoMed Pharmaceut ... | PAKIANATHAN DEEPIKA | Director | Buy | P | 19.00 | 429 | 8,150 | 18,739 | 18.3 K to 18.7 K (+2.34 %) |
| Aug 21 2014 | OMED | OncoMed Pharmaceut ... | PAKIANATHAN DEEPIKA | Director | Buy | P | 19.00 | 45,630 | 866,847 | 1,970,200 | 1.9 M to 2 M (+2.37 %) |
| Aug 21 2014 | OMED | OncoMed Pharmaceut ... | PAKIANATHAN DEEPIKA | Director | Buy | P | 18.89 | 116 | 2,191 | 18,310 | 18.2 K to 18.3 K (+0.64 %) |
| Aug 21 2014 | OMED | OncoMed Pharmaceut ... | PAKIANATHAN DEEPIKA | Director | Buy | P | 18.89 | 12,425 | 234,698 | 1,924,570 | 1.9 M to 1.9 M (+0.65 %) |
| Aug 19 2014 | OMED | OncoMed Pharmaceut ... | LASERSOHN JACK W | Director | Buy | P | 17.00 | 1,045 | 17,765 | 1,045 | 0 to 1 K |
| Aug 12 2014 | OMED | OncoMed Pharmaceut ... | ROOT JONATHAN D | Director | Buy | J | 0.00 | 30,846 | 0 | 63,238 | 32.4 K to 63.2 K (+95.23 %) |
| Aug 12 2014 | OMED | OncoMed Pharmaceut ... | ROOT JONATHAN D | Director | Sell | J | 0.00 | 285,734 | 0 | 0 | 285.7 K to 0 (-100.00 %) |
| Aug 12 2014 | OMED | OncoMed Pharmaceut ... | ROOT JONATHAN D | Director | Buy | J | 0.00 | 285,734 | 0 | 285,734 | 0 to 285.7 K |
| Aug 12 2014 | OMED | OncoMed Pharmaceut ... | ROOT JONATHAN D | Director | Sell | J | 0.00 | 9,046 | 0 | 19,215 | 28.3 K to 19.2 K (-32.01 %) |
| Aug 12 2014 | OMED | OncoMed Pharmaceut ... | ROOT JONATHAN D | Director | Sell | J | 0.00 | 937,205 | 0 | 1,990,783 | 2.9 M to 2 M (-32.01 %) |
| Aug 12 2014 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Buy | J | 0.00 | 27,572 | 0 | 56,528 | 29 K to 56.5 K (+95.22 %) |
| Aug 12 2014 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Buy | J | 0.00 | 8,863 | 0 | 18,170 | 9.3 K to 18.2 K (+95.23 %) |
| Aug 12 2014 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Buy | J | 0.00 | 27,573 | 0 | 27,573 | 0 to 27.6 K |
| Aug 12 2014 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Buy | J | 0.00 | 33,089 | 0 | 50,471 | 17.4 K to 50.5 K (+190.36 %) |
| Aug 12 2014 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Buy | J | 0.00 | 27,573 | 0 | 27,573 | 0 to 27.6 K |
| Aug 12 2014 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Sell | J | 0.00 | 285,734 | 0 | 0 | 285.7 K to 0 (-100.00 %) |
| Aug 12 2014 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Buy | J | 0.00 | 285,734 | 0 | 285,734 | 0 to 285.7 K |
| Aug 12 2014 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Sell | J | 0.00 | 9,046 | 0 | 19,215 | 28.3 K to 19.2 K (-32.01 %) |
| Aug 12 2014 | OMED | OncoMed Pharmaceut ... | PRESIDIO MANAGEMENT GROUP VIII ... | 10% Owner | Sell | J | 0.00 | 937,205 | 0 | 1,990,783 | 2.9 M to 2 M (-32.01 %) |
| Aug 07 2014 | OMED | OncoMed Pharmaceut ... | Hoey Timothy | SVP, Cancer Biology | Option Exercise | M | 1.43 | 2,500 | 3,575 | 45,263 | |
| Aug 07 2014 | OMED | OncoMed Pharmaceut ... | Hoey Timothy | SVP, Cancer Biology | Sell | S | 22.30 | 200 | 4,459 | 49,343 | 49.5 K to 49.3 K (-0.40 %) |
| Aug 07 2014 | OMED | OncoMed Pharmaceut ... | Hoey Timothy | SVP, Cancer Biology | Sell | S | 21.61 | 2,300 | 49,697 | 49,543 | 51.8 K to 49.5 K (-4.44 %) |
| Aug 07 2014 | OMED | OncoMed Pharmaceut ... | Hoey Timothy | SVP, Cancer Biology | Buy | M | 1.43 | 2,500 | 3,575 | 51,843 | 49.3 K to 51.8 K (+5.07 %) |
| Aug 04 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | M | 1.43 | 4,000 | 5,720 | 64,277 | |
| Aug 04 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 20.98 | 4,000 | 83,912 | 20,000 | 24 K to 20 K (-16.67 %) |
| Aug 04 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Buy | M | 1.43 | 4,000 | 5,720 | 24,000 | 20 K to 24 K (+20.00 %) |